MarketBeat
17 May 2026, 22:03 UTC · 19w ago
Verdict
Headline takes no side. We score IART +0.60 across five claims — strongly bullish.
+0.60strongly bullish
More positive than 78% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Integra remains on track to operationalize its Braintree facility in June, build inventory in Q3, and support a Q4 relaunch of SurgiMend into an $800 million double-digit growth market.
More positive than 99% of claims this week
Q1 results showed revenue and EPS above the high end of guidance, with internal indicators like fewer supply disruptions, improved yields, and meaningful cash flow improvement suggesting the operational transformation is gaining traction.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 98% of claims this week
ENT division continues to face reimbursement-related headwinds in balloon sinuplasty that affected 2025 results and are expected to persist into 2026.
More negative than 90% of claims this week
Integra expects leverage to remain just above its 2.5x-3.5x target range at the end of 2026, only falling within the range in 2027, with M&A completely paused until operations stabilize.
More negative than 80% of claims this week
Returning CEO Stuart and the board are giving full backing to the operational transformation initiatives started by the former CEO, keeping the core strategy and focus areas intact.
More positive than 67% of claims this week
Which stocks this story touches
More positive than 78% of ticker scores this week
Q1 results beat guidance, transformation efforts are gaining traction, and multiple product relaunches are underway.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
+14.9%
Price agrees with the score
$16.21 vs $14.10 close before publication (May 15) · not market-adjusted
IART chart →
